145 related articles for article (PubMed ID: 10914946)
21. Prothrombin mutant, factor V Leiden, and thermolabile variant of methylenetetrahydrofolate reductase among patients with sickle cell disease in Brazil.
Andrade FL; Annichino-Bizzacchi JM; Saad ST; Costa FF; Arruda VR
Am J Hematol; 1998 Sep; 59(1):46-50. PubMed ID: 9723576
[TBL] [Abstract][Full Text] [Related]
22. Hyperhomocysteinemia increases the risk of venous thrombosis independent of the C677T mutation of the methylenetetrahydrofolate reductase gene in selected Brazilian patients.
Morelli VM; Lourenço DM; D'Almeida V; Franco RF; Miranda F; Zago MA; Noguti MA; Cruz E; Kerbauy J
Blood Coagul Fibrinolysis; 2002 Apr; 13(3):271-5. PubMed ID: 11943942
[TBL] [Abstract][Full Text] [Related]
23. High frequency of factor V Leiden mutation and prothrombin 20210A variant in Romanies of Eastern Hungary.
Balogh I; Póka R; Losonczy G; Muszbek L
Thromb Haemost; 1999 Nov; 82(5):1555-6. PubMed ID: 10595655
[No Abstract] [Full Text] [Related]
24. The plasminogen activator inhibitor (PAI)-1 promoter 4G/4G genotype is not associated with ischemic stroke in a population of German children. Childhood Stroke Study Group.
Nowak-Göttl U; Sträter R; Kosch A; von Eckardstein A; Schobess R; Luigs P; Nabel P; Vielhaber H; Kurnik K; Junker R
Eur J Haematol; 2001 Jan; 66(1):57-62. PubMed ID: 11168509
[TBL] [Abstract][Full Text] [Related]
25. Placental genotyping of the factor V Leiden, prothrombin 20210A and the methylenetetrahydrofolate reductase (MTHFR) C677T alleles in IUGR pregnancies.
Wisotzkey JD; Bayliss P; Rutherford E; Bell T
Thromb Haemost; 1999 May; 81(5):844-5. PubMed ID: 10365762
[No Abstract] [Full Text] [Related]
26. Coexistence of thrombophilic gene polymorphisms among 559 unrelated consecutive patients with a history of thrombosis.
Madonna P; Piemontino U; De Stefano V; Albisinni R; Cerbone AM; Di Minno G
Thromb Res; 2001 Feb; 101(4):317-9. PubMed ID: 11320983
[No Abstract] [Full Text] [Related]
27. The methylenetetrahydrofolate reductase TT677 genotype is associated with venous thrombosis independently of the coexistence of the FV Leiden and the prothrombin A20210 mutation.
Margaglione M; D'Andrea G; d'Addedda M; Giuliani N; Cappucci G; Iannaccone L; Vecchione G; Grandone E; Brancaccio V; Di Minno G
Thromb Haemost; 1998 May; 79(5):907-11. PubMed ID: 9609218
[TBL] [Abstract][Full Text] [Related]
28. Risk factors for clinical manifestations in carriers of Factor V Leiden and prothrombin gene mutations.
DeSancho MT; Berlus N; Christos PJ; Rand J
Blood Coagul Fibrinolysis; 2010 Jan; 21(1):11-5. PubMed ID: 19474699
[TBL] [Abstract][Full Text] [Related]
29. Factor V Leiden: a genetic risk factor for thrombotic microangiopathy in patients with normal von Willebrand factor-cleaving protease activity.
Raife TJ; Lentz SR; Atkinson BS; Vesely SK; Hessner MJ
Blood; 2002 Jan; 99(2):437-42. PubMed ID: 11781222
[TBL] [Abstract][Full Text] [Related]
30. Factor V Leiden and antiphospholipid antibodies are significant risk factors for ischemic stroke in children.
Kenet G; Sadetzki S; Murad H; Martinowitz U; Rosenberg N; Gitel S; Rechavi G; Inbal A
Stroke; 2000 Jun; 31(6):1283-8. PubMed ID: 10835445
[TBL] [Abstract][Full Text] [Related]
31. Pregnancy, the postpartum period and prothrombotic defects: risk of venous thrombosis in the MEGA study.
Pomp ER; Lenselink AM; Rosendaal FR; Doggen CJ
J Thromb Haemost; 2008 Apr; 6(4):632-7. PubMed ID: 18248600
[TBL] [Abstract][Full Text] [Related]
32. The prevalence of C677T mutation in the methylenetetrahydrofolate reductase gene and its association with venous thrombophilia in Taiwanese Chinese.
Lin JS; Shen MC; Tsai W; Lin B
Thromb Res; 2000 Feb; 97(3):89-94. PubMed ID: 10680639
[TBL] [Abstract][Full Text] [Related]
33. Prothrombin and factor V mutations in women with a history of thrombosis during pregnancy and the puerperium.
Gerhardt A; Scharf RE; Beckmann MW; Struve S; Bender HG; Pillny M; Sandmann W; Zotz RB
N Engl J Med; 2000 Feb; 342(6):374-80. PubMed ID: 10666427
[TBL] [Abstract][Full Text] [Related]
34. Common C677T polymorphism in the methylenetetrahydrofolate reductase gene increases the risk for deep vein thrombosis in patients with predisposition of thrombophilia.
Fujimura H; Kawasaki T; Sakata T; Ariyoshi H; Kato H; Monden M; Miyata T
Thromb Res; 2000 Apr; 98(1):1-8. PubMed ID: 10706928
[TBL] [Abstract][Full Text] [Related]
35. Prevalence of the prothrombin gene 20210A mutation in thrombophilic and healthy Algerian subjects.
Helley D; Chafa O; Yaker NL; Reghis A; Fischer AM
Thromb Haemost; 1999 Nov; 82(5):1554-5. PubMed ID: 10595654
[No Abstract] [Full Text] [Related]
36. Prevalence of genetic markers for thrombophilia in recurrent pregnancy loss.
Carp H; Salomon O; Seidman D; Dardik R; Rosenberg N; Inbal A
Hum Reprod; 2002 Jun; 17(6):1633-7. PubMed ID: 12042290
[TBL] [Abstract][Full Text] [Related]
37. Analyzes of three common thrombophilic gene mutations in German women with recurrent abortions.
Pauer HU; Voigt-Tschirschwitz T; Hinney B; Burfeind P; Wolf C; Emons G; Neesen J
Acta Obstet Gynecol Scand; 2003 Oct; 82(10):942-7. PubMed ID: 12956845
[TBL] [Abstract][Full Text] [Related]
38. Thermolabile methylenetetrahydrofolate reductase and factor V Leiden in the risk of deep-vein thrombosis.
Kluijtmans LA; den Heijer M; Reitsma PH; Heil SG; Blom HJ; Rosendaal FR
Thromb Haemost; 1998 Feb; 79(2):254-8. PubMed ID: 9493571
[TBL] [Abstract][Full Text] [Related]
39. Prevalence of factor V Leiden and prothrombin 20210A mutations in indigenous Australians.
Bennett JA; Palmer LJ; Musk AW; Erber WN
Thromb Haemost; 2001 Dec; 86(6):1592-3. PubMed ID: 11776339
[No Abstract] [Full Text] [Related]
40. Frequency of factor V, prothrombin and methylenetetrahydrofolate reductase gene variants in preeclampsia.
D'Elia AV; Driul L; Giacomello R; Colaone R; Fabbro D; Di Leonardo C; Florio P; Petraglia F; Marchesoni D; Damante G
Gynecol Obstet Invest; 2002; 53(2):84-7. PubMed ID: 11961379
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
